세계의 색전요법 시장 보고서(2025년)

Embolotherapy is a minimally invasive medical procedure that involves deliberately blocking blood vessels to treat various conditions. This is achieved by injecting embolic agents such as microspheres, coils, gels, or liquid embolics into targeted blood vessels, cutting off the blood supply to abnormal tissues or structures. As a highly targeted alternative to traditional surgery, embolotherapy is typically performed by interventional radiologists, offering improved patient outcomes with minimal recovery time.

The primary product types used in embolotherapy include embolization coils, embolic agents, detachable balloons, embolic plug systems, and support devices. Embolization coils are small, flexible devices designed to block blood flow in targeted vessels, treating conditions such as aneurysms, tumors, and vascular malformations. These products are applied in various medical fields, including oncology, peripheral vascular diseases, urology and nephrology, neurology, and gastrointestinal (GIT) disorders. Embolotherapy procedures include transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The key end users of embolotherapy products include ambulatory surgical centers, hospitals, clinics, and other healthcare providers.

The embolotherapy market research report is one of a series of new reports from The Business Research Company that provides embolotherapy market statistics, including the embolotherapy industry global market size, regional shares, competitors with the embolotherapy market share, detailed embolotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the embolotherapy industry. This embolotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The embolotherapy market size has grown strongly in recent years. It will grow from $4.44 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising demand for embolotherapy in treatment, the increasing incidence of cancer and peripheral vascular diseases, growing healthcare expenditure, and higher investment in research.

The embolotherapy market size is expected to see strong growth in the next few years. It will grow to $6.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth during the forecast period can be attributed to rising disposable income, the increasing prevalence of chronic diseases, the growing adoption of embolotherapy in reproductive health, the rising number of chemoembolization procedures, and the increasing incidence of liver cancer. Key trends in the forecast period include advancements in cutting-edge technologies, the development of digital and analog devices, the use of insertable cardiac monitors, innovations in embolotherapy techniques, and strategic collaborations.

The growing preference for minimally invasive procedures is expected to drive the expansion of the embolotherapy market. Minimally invasive procedures involve cosmetic and medical treatments that require little to no surgical intervention, offering benefits such as reduced recovery time, less pain, smaller scars, lower risks of complications, and improved precision due to technological advancements. Embolotherapy supports minimally invasive procedures by selectively blocking blood flow to targeted vessels, reducing bleeding, treating tumors, and managing vascular abnormalities with greater accuracy and fewer complications. For instance, in September 2023, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that cosmetic minimally invasive procedures increased by 7% in 2023, reaching 25,442,640 treatments, up from 23,672,269 in 2022. As a result, the increasing preference for minimally invasive procedures is fueling the growth of the embolotherapy market.

Leading companies in the embolotherapy market are focusing on developing innovative solutions, such as absorbable embolic systems, to enhance patient outcomes and expand treatment options. Absorbable embolic systems are bioresorbable materials used in embolization procedures to block blood flow to targeted tissues, such as tumors or aneurysms, while gradually degrading within the body over time. For example, in January 2025, Instylla Inc., a US-based medical equipment manufacturer, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, a bioresorbable embolization agent made of irregularly shaped, dry-gelatin particles sized between 85 and 255 µm. The system is designed to embolize hypervascular tumors and occlude blood vessels in the peripheral vasculature. According to Instylla, Tembo offers advantages such as easy preparation, high visibility, and the ability to densely pack treated vessels, potentially improving upon existing permanent embolic solutions.

In November 2024, Merit Medical Systems Inc., a US-based healthcare technology company, acquired the Lead Management Portfolio from Cook Medical for approximately $210 million. This acquisition aims to strengthen Merit Medical Systems' electrophysiology (EP) and cardiac rhythm management (CRM) business by expanding its product portfolio and market reach. Cook Medical LLC is a US-based medical device company specializing in embolization coils.

Major players in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc.

North America was the largest region in the embolotherapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in embolotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the embolotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The embolotherapy market consists of revenues earned by entities by providing services such as catheter-based embolization, flow diversion therapy, tumor embolization, uterine fibroid embolization, and endovenous embolization for varicose veins. The market value includes the value of related goods sold by the service provider or included within the service offering. The embolotherapy market also includes sales of microcatheters, liquid embolic agents, particle embolic agents, balloon occlusion devices, and flow diverters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Embolotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on embolotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for embolotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The embolotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Embolization Coil; Embolic Agents; Detachable Balloons; Embolic Plug Systems; Support Devices
• 2) By Application: Oncology; Peripheral Vascular Diseases; Urology and Nephrology; Neurology; Gastrointestinal (GIT) Disorders
• 3) By Procedure: Transcatheter Arterial Embolization (TAE); Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT); Transarterial Chemoembolization (TACE)
• 4) By End User: Ambulatory Surgical Centre; Hospitals And Clinics; Other End Users
• Subsegments:
• 1) By Embolization Coil: Bare Coils; Coated Coils; Micro Coils
• 2) By Embolic Agents: Liquid Embolic Agents; Particulate Embolic Agents; Gelatin Sponge; Polyvinyl Alcohol (PVA) Particles
• 3) By Detachable Balloons: Single-Use Balloons; Multi-Use Balloons
• 4) By Embolic Plug Systems: Plug Kits; Distal Occlusion Systems
• 5) By Support Devices: Guidewires; Catheters; Sheath Introducers
• Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation ; Medtronic PLC; Johnson And Johnson; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Embolotherapy Market Characteristics

3. Embolotherapy Market Trends And Strategies

4. Embolotherapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Embolotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Embolotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Embolotherapy Market Growth Rate Analysis
• 5.4. Global Embolotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Embolotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Embolotherapy Total Addressable Market (TAM)

6. Embolotherapy Market Segmentation

• 6.1. Global Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embolization Coil
• Embolic Agents
• Detachable Balloons
• Embolic Plug Systems
• Support Devices
• 6.2. Global Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Peripheral Vascular Diseases
• Urology and Nephrology
• Neurology
• Gastrointestinal (GIT) Disorders
• 6.3. Global Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Arterial Embolization (TAE)
• Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT)
• Transarterial Chemoembolization (TACE)
• 6.4. Global Embolotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Centre
• Hospitals And Clinics
• Other End Users
• 6.5. Global Embolotherapy Market, Sub-Segmentation Of Embolization Coil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bare Coils
• Coated Coils
• Micro Coils
• 6.6. Global Embolotherapy Market, Sub-Segmentation Of Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Embolic Agents
• Particulate Embolic Agents
• Gelatin Sponge
• Polyvinyl Alcohol (PVA) Particles
• 6.7. Global Embolotherapy Market, Sub-Segmentation Of Detachable Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Balloons
• Multi-Use Balloons
• 6.8. Global Embolotherapy Market, Sub-Segmentation Of Embolic Plug Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plug Kits
• Distal Occlusion Systems
• 6.9. Global Embolotherapy Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Guidewires
• Catheters
• Sheath Introducers

7. Embolotherapy Market Regional And Country Analysis

• 7.1. Global Embolotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Embolotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Embolotherapy Market

• 8.1. Asia-Pacific Embolotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Embolotherapy Market

• 9.1. China Embolotherapy Market Overview
• 9.2. China Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Embolotherapy Market

• 10.1. India Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Embolotherapy Market

• 11.1. Japan Embolotherapy Market Overview
• 11.2. Japan Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Embolotherapy Market

• 12.1. Australia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Embolotherapy Market

• 13.1. Indonesia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Embolotherapy Market

• 14.1. South Korea Embolotherapy Market Overview
• 14.2. South Korea Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Embolotherapy Market

• 15.1. Western Europe Embolotherapy Market Overview
• 15.2. Western Europe Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Embolotherapy Market

• 16.1. UK Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Embolotherapy Market

• 17.1. Germany Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Embolotherapy Market

• 18.1. France Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Embolotherapy Market

• 19.1. Italy Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Embolotherapy Market

• 20.1. Spain Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Embolotherapy Market

• 21.1. Eastern Europe Embolotherapy Market Overview
• 21.2. Eastern Europe Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Embolotherapy Market

• 22.1. Russia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Embolotherapy Market

• 23.1. North America Embolotherapy Market Overview
• 23.2. North America Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Embolotherapy Market

• 24.1. USA Embolotherapy Market Overview
• 24.2. USA Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Embolotherapy Market

• 25.1. Canada Embolotherapy Market Overview
• 25.2. Canada Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Embolotherapy Market

• 26.1. South America Embolotherapy Market Overview
• 26.2. South America Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Embolotherapy Market

• 27.1. Brazil Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Embolotherapy Market

• 28.1. Middle East Embolotherapy Market Overview
• 28.2. Middle East Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Embolotherapy Market

• 29.1. Africa Embolotherapy Market Overview
• 29.2. Africa Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Embolotherapy Market Competitive Landscape And Company Profiles

• 30.1. Embolotherapy Market Competitive Landscape
• 30.2. Embolotherapy Market Company Profiles
  • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Embolotherapy Market Other Major And Innovative Companies

• 31.1. Sirtex Medical
• 31.2. Abbott Laboratories
• 31.3. Acandis GmbH
• 31.4. Balt Group LLC
• 31.5. Penumbra Inc
• 31.6. Merit Medical Systems
• 31.7. Kaneka Corporation
• 31.8. Meril Life Sciences Pvt. Ltd.
• 31.9. Shape Memory Medical Inc
• 31.10. Guerbet
• 31.11. IMBiotechnologies Ltd
• 31.12. Cardiva
• 31.13. Rapid Medical
• 31.14. Emboline Inc
• 31.15. Microport Scientific

32. Global Embolotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Embolotherapy Market

34. Recent Developments In The Embolotherapy Market

35. Embolotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Embolotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Embolotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Embolotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer